EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study

N Norén, I Rouvelas, L Lundell, M Nilsson, B Sunde, E Szabo, D Edholm, J Hedberg, U Smedh, M Hermansson, M Lindblad, F Klevebro

Langenbeck's Archives of Surgery · 2024

DOI: 10.1007/s00423-024-03575-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Langenbeck's Archives of Surgery, 2024. Verfasst von N Norén und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Oncology, CLINTEC, Karolinska Institutet, Dep. of Upper Gastrointestinal Diseases, Karolinska University Hospital, Stockhol…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Oligometastatic gastroesophageal cancer is a clinical entity with no standard treatment recommendation. Treatment with curative intent has recently emerged as an option for selected patients in contrast to the traditional palliative treatment strategy. This prospective study aimed to assess the safety and efficacy of combined systemic and local treatment with curative intent for patients with oligometastatic gastroesophageal cancer.

Methods

In a multicenter study, consecutive patients with gastroesophageal cancer and metastases in the liver and/or extra-regional lymph nodes were screened for inclusion. Eligible patients were offered curatively intended perioperative chemotherapy followed by surgical resection or liver ablation. Primary endpoints were treatment safety and feasibility. Secondary outcomes included postoperative mortality, treatment response, progression-free survival, and overall survival. Subgroup analyses were stratified based on oligometastatic location.

Results

A total of 29 (82.9%) patients completed treatment with surgical resection (93.1%), liver ablation (3.4%), or definitive chemoradiotherapy (3.4%). Postoperative complications were found in 19 (73.1%) patients, whereas postoperative mortality was 0%. The most common complications included infection (34.6%) and respiratory complications (34.6%). Median overall survival was 20.9 months (interquartile range 11.2–42.6) from diagnosis and 17.0 months (interquartile range 6.4–35.9) from surgery in patients who were treated with neoadjuvant chemotherapy followed by surgery. Median progression-free survival was 5.8 months (interquartile range 3.1–11.3).

Conclusion

This study found curative treatment to be a relatively safe option, with an overall survival of 20.8 months and no postoperative mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsStomach NeoplasmsHumansMaleFemaleProspective StudiesMiddle AgedAgedLiver NeoplasmsTreatment OutcomeCombined Modality TherapyLymphatic MetastasisSurvival Rate

Stichwörter der Autor:innen

Esophageal cancerGastric cancerOligometastatic gastroesophageal cancerOverall survivalPostoperative complications

Autor:innen und Institutionen

  • Department of Surgery and Oncology, CLINTEC, Karolinska Institutet, Dep. of Upper Gastrointestinal Diseases, Karolinska University Hospital, Stockholm, Sweden. nora.noren@ki.se.
  • Department of Surgery and Oncology, CLINTEC, Karolinska Institutet, Dep. of Upper Gastrointestinal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Surgery, Odense University Hospital, Odense, Denmark.
  • Örebro University Hospital, Örebro, Sweden.
  • Department of Surgery, Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Förderung

  • Karolinska Institute

Zitieren

APA

Norén, N., Rouvelas, I., Lundell, L., Nilsson, M., Sunde, B., Szabo, E., Edholm, D., Hedberg, J., Smedh, U., Hermansson, M., Lindblad, M., & Klevebro, F. (2024). Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-024-03575-7

Vancouver

Norén N, Rouvelas I, Lundell L, Nilsson M, Sunde B, Szabo E, et al. Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study. Langenbeck's Archives of Surgery. 2024. doi:10.1007/s00423-024-03575-7

BibTeX
@article{Norn2024,
  author = {Norén, N and Rouvelas, I and Lundell, L and Nilsson, M and Sunde, B and Szabo, E and Edholm, D and Hedberg, J and Smedh, U and Hermansson, M and Lindblad, M and Klevebro, F},
  title = {Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study},
  journal = {Langenbeck's Archives of Surgery},
  year = {2024},
  doi = {10.1007/s00423-024-03575-7}
}
Kostenlos starten →